M
Mark E. Cooper
Researcher at University of Queensland
Publications - 1514
Citations - 141899
Mark E. Cooper is an academic researcher from University of Queensland. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 158, co-authored 1463 publications receiving 124887 citations. Previous affiliations of Mark E. Cooper include University of Cambridge & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Profiling of molecular interactions in real time using acoustic detection.
Benjamin Godber,Mark John Frogley,Marian Rehak,Alexander Sleptsov,Kevin S.J. Thompson,Yildiz Uludag,Mark E. Cooper +6 more
TL;DR: This work has developed a novel acoustic detection technology, which they term resonant acoustic profiling (RAP), which builds on the fundamental basics of the "quartz crystal microbalance" or "QCM" with several key additional features including two- or four-channel automated sample delivery, in-line referencing and microfluidic sensor 'cassettes' that are pre-coated with easy-to-use surface chemistries.
Three-mode analytical methods for crop improvement programs
TL;DR: In this paper, two complementary ordination and clustering procedures, three-way principal component analysis and threeway mixture approach to clustering, were used to analyse multi-environment data.
Journal ArticleDOI
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD
David M. Charytan,Scott D. Solomon,Peter Ivanovich,Giuseppe Remuzzi,Mark E. Cooper,Janet B. McGill,Hans-Henrik Parving,Patrick S. Parfrey,Ajay K. Singh,Emmanuel A. Burdmann,Andrew S. Levey,Dick de Zeeuw,Kai-Uwe Eckardt,John J.V. McMurray,Brian Claggett,Eldrin F. Lewis,Marc A. Pfeffer +16 more
TL;DR: Most ESRD cases occurred in individuals without intercurrent CV events who had lower eGFRs than individuals with intercurrentCV events, but similar post-ESRD mortality, underscoring the need for kidney-specific therapies in addition to treatment of CV risk factors to lower E SRD incidence in diabetes.
Journal ArticleDOI
SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.
K. Jandeleit-Dahm,Jonathan R. Rumble,Alison J. Cox,Darren J. Kelly,Marie Dziadek,Mark E. Cooper,Richard E. Gilbert +6 more
TL;DR: Diabetes-related mesenteric vascular hypertrophy is associated with an increase in SPARC expression in the vessel wall, which might be of pathogenetic significance in the development of vascular remodeling in diabetes.
Journal ArticleDOI
A paramagnetic-reporter two-particle system for amplification-free detection of DNA in serum.
TL;DR: A amplification-free herpes simplex virus (HSV) assay where oligoethylene glycol methacrylate grafted ssDNA capture-probes on paramagnetic nanoparticles are coupled with reporter-probe-modified fluorescent nanoparticles in a target-dependent manner is reported.